{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:22:10Z","timestamp":1792786930327,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009340","name":"Washington University in Saint Louis Children's Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Saint Louise Children's Hospital","id":[{"id":"https:\/\/ror.org\/0511k4970","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtct.2025.06.015","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:44:51Z","timestamp":1750301091000},"page":"826.e1-826.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-4921","authenticated-orcid":false,"given":"Niketa C.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-5642","authenticated-orcid":false,"given":"Alexander","family":"Ngwube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-7182","authenticated-orcid":false,"given":"Tara","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-0887","authenticated-orcid":false,"given":"Allistair","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-3102","authenticated-orcid":false,"given":"Eric","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6520-6132","authenticated-orcid":false,"given":"Martin","family":"Andreansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8757","authenticated-orcid":false,"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2056-5167","authenticated-orcid":false,"given":"Michael","family":"Grimley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-3270","authenticated-orcid":false,"given":"David","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-8874","authenticated-orcid":false,"given":"Naynesh","family":"Kamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-965X","authenticated-orcid":false,"given":"Jennifer","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmanan","family":"Krishnamurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shermini","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Skiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9283-607X","authenticated-orcid":false,"given":"Shalini","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0001","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.3324\/haematol.2019.216788","article-title":"Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease","volume":"104","author":"Cappelli","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0003","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/bbmt.2001.v7.pm11787529","article-title":"Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia","volume":"7","author":"Walters","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0004","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","article-title":"Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling","volume":"122","author":"Locatelli","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.06.015_bib0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/bmt.2014.84","article-title":"Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease","volume":"49","author":"Bhatia","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0006","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.015_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00062752-200003000-00004","article-title":"Bone marrow transplantation for hemoglobinopathies","volume":"7","author":"Mentzer","year":"2000","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.015_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00001622-200103000-00001","article-title":"Bone marrow transplantation in sickle cell anemia","volume":"13","author":"Hoppe","year":"2001","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0009","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbmt.2014.09.010","article-title":"High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink?","volume":"21","author":"Mohty","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0010","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbmt.2008.08.016","article-title":"Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease","volume":"14","author":"Krishnamurti","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.015_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0012","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2019.02.011","article-title":"Nonmyeloablative matched sibling donor hematopoietic cell transplantation in children and adolescents with sickle cell disease","volume":"25","author":"Guilcher","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0013","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ajh.24183","article-title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","volume":"90","author":"King","year":"2015","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1016\/j.jtct.2025.06.015_bib0014","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood-2016-05-715870","article-title":"A trial of unrelated donor marrow transplantation for children with severe sickle cell disease","volume":"128","author":"Shenoy","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2018.01.023","article-title":"Unrelated donor transplantation in children with thalassemia using reduced-intensity conditioning: the URTH trial","volume":"24","author":"Shenoy","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0016","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(19)30031-6","article-title":"Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0017","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","article-title":"Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative","volume":"25","author":"de la Fuente","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.015_bib0018","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbmt.2017.05.027","article-title":"Unrelated umbilical cord blood transplantation for sickle cell disease following reduced-intensity conditioning: results of a phase I trial","volume":"23","author":"Abraham","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0020","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2013.09.003","article-title":"In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial","volume":"19","author":"Koura","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231152644","article-title":"Role of abatacept in the prevention of graft-versus-host disease: current perspectives","volume":"14","author":"Ngwube","year":"2023","journal-title":"Ther Adv Hematol"},{"issue":"17","key":"10.1016\/j.jtct.2025.06.015_bib0022","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.015_bib0023","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1172\/JCI98793","article-title":"CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates","volume":"128","author":"Watkins","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2025.06.015_bib0024","series-title":"FDA Approves Abatacept for Prophylaxis of Acute Graft Versus Host Disease [Press Release]","year":"2021"},{"issue":"16","key":"10.1016\/j.jtct.2025.06.015_bib0025","first-page":"3894","article-title":"Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease","volume":"4","author":"Ngwube","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0026","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0027","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0028","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.jtct.2021.12.016","article-title":"Granulocyte colony-stimulating factor is safe and well tolerated following allogeneic transplantation in patients with sickle cell disease","volume":"28","author":"Shah","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.015_bib0029","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08880018.2021.2013369","article-title":"Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: a case series","volume":"39","author":"Ngwube","year":"2022","journal-title":"Pediatr Hematol Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.015_bib0030","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41409-022-01749-9","article-title":"CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease","volume":"57","author":"Rangarajan","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0031","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/jcm11113118","article-title":"Long-term health effects of curative therapies on heart, lungs, and kidneys for individuals with sickle cell disease compared to those with hematologic malignancies","volume":"11","author":"Fitzhugh","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.jtct.2025.06.015_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29927","article-title":"Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation","volume":"69","author":"Monagel","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0033","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2018.20059","article-title":"Association of matched sibling donor hematopoietic stem cell transplantation with transcranial doppler velocities in children with sickle cell anemia","volume":"321","author":"Bernaudin","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.015_bib0034","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/s41409-021-01298-7","article-title":"Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation","volume":"56","author":"Friedman","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.06.015_bib0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbmt.2009.10.005","article-title":"Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease","volume":"16","author":"Walters","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.2022016618","article-title":"Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease","volume":"141","author":"Hulbert","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.06.015_bib0037","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/pbc.25904","article-title":"Improved splenic function after hematopoietic stem cell transplant for sickle cell disease","volume":"63","author":"Nickel","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.015_bib0038","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/bloodadvances.2023010749","article-title":"Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease","volume":"8","author":"Krishnamurti","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0039","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbmt.2014.12.007","article-title":"Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease","volume":"21","author":"Bhatia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.015_bib0040","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.bbmt.2017.05.033","article-title":"Posterior reversible encephalopathy syndrome after hematopoietic cell transplantation in children with hemoglobinopathies","volume":"23","author":"Gaziev","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.015_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15164","article-title":"Posterior reversible encephalopathy syndrome in pediatric hematopoietic stem cell transplantation with beta major thalassemia: the association between the PRES occurrence and class of beta major thalassemia","volume":"38","author":"Jafari","year":"2024","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0042","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.22.01203","article-title":"Secondary neoplasms after hematopoietic cell transplant for sickle cell disease","volume":"41","author":"Eapen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0043","doi-asserted-by":"crossref","first-page":"770.e1","DOI":"10.1016\/j.jtct.2022.08.014","article-title":"Comparison of anti-mullerian hormone levels pre- and post-hematopoietic cell transplantation in pediatric and adolescent females with sickle cell disease","volume":"28","author":"George","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"23","key":"10.1016\/j.jtct.2025.06.015_bib0044","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.2022017960","article-title":"Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism","volume":"140","author":"Lawal","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1704795","article-title":"A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders","volume":"35","author":"Shenoy","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.06.015_bib0046","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2023020035","article-title":"Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events","volume":"142","author":"Takahashi","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.06.015_bib0047","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ajh.27251","article-title":"Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial","volume":"99","author":"Eapen","year":"2024","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.jtct.2025.06.015_bib0048","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","article-title":"Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study","volume":"6","author":"Eapen","year":"2019","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.06.015_bib0049","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjh.19122","article-title":"Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: a study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties","volume":"204","author":"Cseh","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbmt.2018.10.008","article-title":"Immune reconstitution and infection patterns after early alemtuzumab and reduced intensity transplantation for nonmalignant disorders in pediatric patients","volume":"25","author":"Bhatt","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.06.015_bib0051","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4: B7\/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0052","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/bloodadvances.2021005208","article-title":"Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation","volume":"6","author":"Qayed","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.06.015_bib0053","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trim.2017.07.004","article-title":"T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia","volume":"43-44","author":"Jaiswal","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jtct.2025.06.015_bib0054","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2021-150742","volume":"138","author":"Kean","year":"2021","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0055","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.bbmt.2017.12.674","article-title":"Abatacept for GVHD prophylaxis after hematopoietic stem cell transplantation (HCT) for pediatric sickle cell disease (SCD): a Sickle Transplant Alliance for Research (STAR) trial","volume":"24","author":"Chaudhury","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.06.015_bib0056","doi-asserted-by":"crossref","first-page":"605.e1","DOI":"10.1016\/j.jtct.2024.03.010","article-title":"Long-term follow-up of abatacept, post-transplantation cyclophosphamide, and sirolimus-based haploidentical transplantation in younger patients with nonmalignant diseases","volume":"30","author":"Jaiswal","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jtct.2025.06.015_bib0057","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.157.9.4258","article-title":"Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD","volume":"157","author":"Via","year":"1996","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.jtct.2025.06.015_bib0058","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National marrow donor program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.jtct.2025.06.015_bib0059","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2025.06.015_bib0060","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood-2022-165229","volume":"140","author":"Kassim","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.06.015_bib0061","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400192","article-title":"Haploidentical bone marrow transplantation for sickle cell disease","volume":"4","author":"Kassim","year":"2025","journal-title":"NEJM Evid"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:57:45Z","timestamp":1759881465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666636725012576"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}